June 8, 2015 /PRNewswire/ -- Cordis Corporation
announced today the launch of the new ELITECROSS(TM) Support Catheter in the United States and OUTBACK[sup.
has launched SABER PTA Dilatation Catheter (SABER Catheter) for the treatment of patients with Peripheral Arterial Disease (PAD).
WATERLOO, Belgium, April 6, 2010 /PRNewswire/ -- Cordis Corporation
announced that Christian M.
and Boston Scientific Corporation infringed coronary stent patents owned by the Cordis Corporation
(Warren, NJ), a Johnson & Johnson company.
R] Stent," said Shlomi Nachman, Worldwide President, Cordis Corporation
WATERLOO, Belgium, March 11, 2010 /PRNewswire/ -- Cordis Corporation
today announced the European launch of its next generation of bare metal stent system - PRESILLION(TM) PLUS.
1 /PRNewswire/ -- Cordis Corporation
, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific resolving two Delaware litigations related to Cordis's Palmaz and Gray patents and Boston Scientific's Jang patents.
2 billion, to Cordis Corporation
against Medtronic, Inc.
(Miami, FL), a Johnson & Johnson (New Brunswick, NJ) company, announced that United States District Judge Sue Robinson upheld two March 2005 jury verdicts that Cordis' pioneering patents for balloon expandable stents were valid and infringed by Boston Scientific Corporation and Medtronic, Inc.
today announced the presentation of the SAPPHIRE study results for the first 15,000 patients at the TCT 2012 conference in Miami.
Today at the 61st Annual Meeting of the Society for Vascular Surgery, Cordis Endovascular, division of Cordis Corporation
, announced the worldwide launch of the Cordis AVIATOR(TM) Plus Balloon Dilatation Catheter for use in angioplasty procedures for patients with carotid and or renal artery blockages.
Developed and manufactured by Cordis Corporation
, the CYPHER(R) Stent is currently available in more than 80 countries and has the longest-term clinical follow-up of any drug-eluting stent.